bone morphogenetic protein 4
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| negative regulation of transcription by RNA polymerase II | ||
| negative regulation of transcription by RNA polymerase II | ||
| skeletal system development | ||
| skeletal system development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular space | ||
| extracellular space | ||
| extracellular space |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine activity | ||
| cytokine activity | ||
| protein binding | ||
| growth factor activity | ||
| growth factor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050651 | atrioventricular septal defect | |
| DOID:0080015 | physical disorder | |
| DOID:0080313 | cleft palate-lateral synechia syndrome | |
| DOID:0110122 | Axenfeld-Rieger syndrome type 3 | |
| DOID:13374 | fibrodysplasia ossificans progressiva | |
| DOID:18 | urinary system disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026